Daré Bioscience Inc.

NASDAQ: DARE · Real-Time Price · USD
2.19
0.12 (5.80%)
At close: Aug 15, 2025, 3:59 PM
2.15
-1.60%
After-hours: Aug 15, 2025, 06:59 PM EDT

Daré Bioscience Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
15.7M 10.48M 34.67M 51.67M
Short-Term Investments
15.68B n/a n/a n/a
Long-Term Investments
n/a 335K n/a n/a
Other Long-Term Assets
810.59K 1.43M 264.8K 268.45K
Receivables
229.98K 949.21K 1.7M 1.15M
Inventory
n/a n/a n/a -2.47B
Other Current Assets
n/a n/a n/a n/a
Total Current Assets
18.45M 17.54M 43.04M 55.3M
Property-Plant & Equipment
2.54M 1.98M 522.83K 242.71K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
3.65M 3.74M 787.63K 511.16K
Total Assets
22.1M 21.28M 43.83M 55.81M
Account Payables
1.46M 3.39M 2.03M 2.1M
Deferred Revenue
16.56M 13.74M 18.3M 10.54M
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
2.24M 2.08M 9.17M 1.53M
Total Current Liabilities
21.61M 20.48M 31.62M 16.05M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
5.75M 3.91M n/a n/a
Total Long-Term Liabilities
6.5M 5.85M 1.09M 1M
Total Liabilities
28.11M 26.33M 32.71M 17.05M
Total Debt
1.3M 1.4M 488.74K 270.55K
Common Stock
870.00 10K 8.48K 8.39K
Retained Earnings
-175.29B -171.24M -141.07M -110.13M
Comprehensive Income
-428.81M -360.9K -351.31K -154.97K
Shareholders Equity
-6.01B -5.05M 11.11M 38.75M
Total Investments
15.68B 335K n/a n/a